Related Experiment Video
Updated: Apr 18, 2026

Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
ZBTB2 increases PDK4 expression by transcriptional repression of RelA/p65
Min-Young Kim1, Dong-In Koh1, Won-Il Choi1
1Department of Biochemistry and Molecular Biology, Brain Korea 21 Plus Project for Medical Science, Severance Biomedical Research Institute, Yonsei University School of Medicine, 50-1 Yonsei-Ro, SeoDaeMun-Gu, Seoul 120-752, Korea.
Abstract:
The NF-κB is found in almost all animal cell types and is involved in a myriad of cellular responses. Aberrant expression of NF-κB has been linked to cancer, inflammatory diseases and improper development. Little is known about transcriptional regulation of the NF-κB family member gene RelA/p65. Sp1 plays a key role in the expression of the RelA/p65 gene. ZBTB2 represses transcription of the gene by inhibiting Sp1 binding to a Sp1-binding GC-box in the RelA/p65 proximal promoter (bp, -31 to -21). Moreover, recent studies revealed that RelA/p65 directly binds to the peroxisome proliferator-activated receptor-γ coactivator1α (PGC1α) to decrease transcriptional activation of the PGC1α target gene PDK4, whose gene product inhibits pyruvate dehydrogenase (PDH), a key regulator of TCA cycle flux. Accordingly, we observed that RelA/p65 repression by ZBTB2 indirectly results in increased PDK4 expression, which inhibits PDH. Consequently, in cells with ectopic ZBTB2, the concentrations of pyruvate and lactate were higher than those in normal cells, indicating changes in glucose metabolism flux favoring glycolysis over the TCA cycle. Knockdown of ZBTB2 in mouse xenografts decreased tumor growth. ZBTB2 may increase cell proliferation by reprogramming glucose metabolic pathways to favor glycolysis by upregulating PDK4 expression via repression of RelA/p65 expression.
Insights
ZBTB2 represses the RelA/p65 gene, altering glucose metabolism and promoting glycolysis. This reprogramming of metabolic pathways by ZBTB2 may drive cancer cell proliferation.
Area of Science:
- Cellular biology
- Molecular oncology
- Metabolic pathways
Background:
- Nuclear factor-kappa B (NF-κB) pathway is crucial for cellular responses, with aberrant expression linked to cancer.
- The transcriptional regulation of NF-κB family member RelA/p65 is not well understood.
- Sp1 transcription factor is vital for RelA/p65 gene expression.
Purpose of the Study:
- To investigate the role of ZBTB2 in regulating RelA/p65 gene transcription.
- To elucidate the impact of ZBTB2-mediated RelA/p65 repression on glucose metabolism and cancer progression.
Main Methods:
- Analysis of ZBTB2's effect on Sp1 binding to the RelA/p65 promoter.
- Assessment of PDK4 and pyruvate dehydrogenase (PDH) activity.
- Measurement of pyruvate and lactate levels in cells with ectopic ZBTB2.
- Evaluation of tumor growth in mouse xenografts with ZBTB2 knockdown.
Main Results:
- ZBTB2 inhibits Sp1 binding to the RelA/p65 promoter, repressing RelA/p65 transcription.
- Repression of RelA/p65 by ZBTB2 leads to increased PDK4 expression and PDH inhibition.
- Cells with ectopic ZBTB2 exhibit elevated pyruvate and lactate, indicating a shift towards glycolysis.
- Knockdown of ZBTB2 reduces tumor growth in mouse models.
Conclusions:
- ZBTB2 promotes glycolysis over the TCA cycle by upregulating PDK4 expression via RelA/p65 repression.
- ZBTB2 may enhance cell proliferation by reprogramming glucose metabolism, suggesting it as a potential therapeutic target in cancer.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
10:05Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
Published on: March 5, 2019
Related Concept Videos
Abnormal Proliferation
Co-activators and Co-repressors
TGF - β Signaling Pathway
RNA Polymerase II Accessory Proteins
Cell Specific Gene Expression
Negative Regulator Molecules